Article Details
Retrieved on: 2024-05-01 15:57:31
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the market research report for Paroxysmal Nocturnal Hemoglobinuria (PNH), highlighting a growing market, PNH epidemiology, and therapeutics like monoclonal antibodies, immuno-suppressants, and orphan drugs like Eculizumab and Pegcetacoplan by firms such as Alexion Pharmaceuticals.
Article found on: www.openpr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here